Related Experiment Video

Updated: Jul 22, 2026

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
06:38

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

What can oncologists learn from HIV?

Justin Stebbing1, Mark Bower

  • 1Chelsea and Westminster Hospital, London, UK.

The Lancet. Oncology
|July 10, 2003
PubMed

Insights

Oncologists can learn valuable lessons from the human immunodeficiency virus (HIV) epidemic, particularly regarding rapid therapeutic advancements and community involvement in research. These insights can improve cancer care and patient outcomes.

Area of Science:

  • Oncology
  • Infectious Diseases
  • Public Health

Background:

  • The human immunodeficiency virus (HIV) epidemic has spurred rapid advancements in medical research and patient care.
  • Political influence and community engagement have significantly shaped the trajectory of HIV research and treatment.

Purpose of the Study:

  • To review the key developments in HIV medicine.
  • To identify transferable lessons for oncologists from the HIV epidemic.
  • To explore how HIV research has influenced drug design and patient care strategies.

Main Methods:

  • Literature review of HIV-related medical developments.
  • Analysis of the impact of political and community factors on HIV research.
  • Discussion of therapeutic targeting, resistance detection, and surrogate endpoints in HIV studies.

Main Results:

  • Rational drug design has drastically reduced HIV morbidity and mortality.
  • Predictive surrogate endpoints are now crucial for evaluating new treatment protocols.
  • Routine resistance detection enables personalized HIV therapies.
  • Community involvement has proven effective in developing and implementing preventive strategies.

Conclusions:

  • The HIV epidemic offers a model for rapid medical progress and adaptive research strategies.
  • Oncologists can benefit from understanding HIV research methodologies, including personalized medicine and community-based participatory research.
  • Lessons from HIV management can enhance the standard of care in oncology, particularly in areas of drug development and patient advocacy.

More Related Videos

Isolation, Transfection, and Culture of Primary Human Monocytes09:13

Isolation, Transfection, and Culture of Primary Human Monocytes

Published on: December 16, 2019

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice06:07

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...